166 related articles for article (PubMed ID: 35067102)
1. Allele-specific silencing by RNAi of R92Q and R173W mutations in cardiac troponin T.
Migliore L; Galvagni F; Pierantozzi E; Sorrentino V; Rossi D
Exp Biol Med (Maywood); 2022 May; 247(10):805-814. PubMed ID: 35067102
[TBL] [Abstract][Full Text] [Related]
2. Establishing a new human hypertrophic cardiomyopathy-specific model using human embryonic stem cells.
Cai H; Li B; Bai A; Huang J; Zhan Y; Sun N; Liang Q; Xu C
Exp Cell Res; 2020 Feb; 387(1):111736. PubMed ID: 31759053
[TBL] [Abstract][Full Text] [Related]
3. The role of cardiac troponin T quantity and function in cardiac development and dilated cardiomyopathy.
Ahmad F; Banerjee SK; Lage ML; Huang XN; Smith SH; Saba S; Rager J; Conner DA; Janczewski AM; Tobita K; Tinney JP; Moskowitz IP; Perez-Atayde AR; Keller BB; Mathier MA; Shroff SG; Seidman CE; Seidman JG
PLoS One; 2008 Jul; 3(7):e2642. PubMed ID: 18612386
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of Hypertrophic Cardiomyopathy is Mutation Rather Than Disease Specific: A Comparison of the Cardiac Troponin T E163R and R92Q Mouse Models.
Ferrantini C; Coppini R; Pioner JM; Gentile F; Tosi B; Mazzoni L; Scellini B; Piroddi N; Laurino A; Santini L; Spinelli V; Sacconi L; De Tombe P; Moore R; Tardiff J; Mugelli A; Olivotto I; Cerbai E; Tesi C; Poggesi C
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28735292
[TBL] [Abstract][Full Text] [Related]
5. Clinical and Prognostic Profiles of Cardiomyopathies Caused by Mutations in the Troponin T Gene.
Ripoll-Vera T; Gámez JM; Govea N; Gómez Y; Núñez J; Socías L; Escandell Á; Rosell J
Rev Esp Cardiol (Engl Ed); 2016 Feb; 69(2):149-58. PubMed ID: 26507537
[TBL] [Abstract][Full Text] [Related]
6. Genetic variation screening of TNNT2 gene in a cohort of patients with hypertrophic and dilated cardiomyopathy.
Jáchymová M; Muravská A; Paleček T; Kuchynka P; Řeháková H; Magage S; Král A; Zima T; Horký K; Linhart A
Physiol Res; 2012; 61(2):169-75. PubMed ID: 22292720
[TBL] [Abstract][Full Text] [Related]
7. Development of a Cardiac Sarcomere Functional Genomics Platform to Enable Scalable Interrogation of Human
Pettinato AM; Ladha FA; Mellert DJ; Legere N; Cohn R; Romano R; Thakar K; Chen YS; Hinson JT
Circulation; 2020 Dec; 142(23):2262-2275. PubMed ID: 33025817
[TBL] [Abstract][Full Text] [Related]
8. A perspective on Notch signalling in progression and arrhythmogenesis in familial hypertrophic and dilated cardiomyopathies.
Langa P; Shafaattalab S; Goldspink PH; Wolska BM; Fernandes AA; Tibbits GF; Solaro RJ
Philos Trans R Soc Lond B Biol Sci; 2023 Jun; 378(1879):20220176. PubMed ID: 37122209
[TBL] [Abstract][Full Text] [Related]
9. Allele-specific silencing of mutant Myh6 transcripts in mice suppresses hypertrophic cardiomyopathy.
Jiang J; Wakimoto H; Seidman JG; Seidman CE
Science; 2013 Oct; 342(6154):111-4. PubMed ID: 24092743
[TBL] [Abstract][Full Text] [Related]
10. Clinical and functional characterization of TNNT2 mutations identified in patients with dilated cardiomyopathy.
Hershberger RE; Pinto JR; Parks SB; Kushner JD; Li D; Ludwigsen S; Cowan J; Morales A; Parvatiyar MS; Potter JD
Circ Cardiovasc Genet; 2009 Aug; 2(4):306-13. PubMed ID: 20031601
[TBL] [Abstract][Full Text] [Related]
11. Effects of troponin T cardiomyopathy mutations on the calcium sensitivity of the regulated thin filament and the actomyosin cross-bridge kinetics of human β-cardiac myosin.
Sommese RF; Nag S; Sutton S; Miller SM; Spudich JA; Ruppel KM
PLoS One; 2013; 8(12):e83403. PubMed ID: 24367593
[TBL] [Abstract][Full Text] [Related]
12. Cardiac troponin T (TNNT2) mutations in chinese dilated cardiomyopathy patients.
Li X; Luo R; Gu H; Deng Y; Xu X; Wu X; Hua W
Biomed Res Int; 2014; 2014():907360. PubMed ID: 25110706
[TBL] [Abstract][Full Text] [Related]
13. Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy.
Tardiff JC; Hewett TE; Palmer BM; Olsson C; Factor SM; Moore RL; Robbins J; Leinwand LA
J Clin Invest; 1999 Aug; 104(4):469-81. PubMed ID: 10449439
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms and structural features of cardiomyopathy-causing troponin T mutants in the tropomyosin overlap region.
Gangadharan B; Sunitha MS; Mukherjee S; Chowdhury RR; Haque F; Sekar N; Sowdhamini R; Spudich JA; Mercer JA
Proc Natl Acad Sci U S A; 2017 Oct; 114(42):11115-11120. PubMed ID: 28973951
[TBL] [Abstract][Full Text] [Related]
15. Severe disease expression of cardiac troponin C and T mutations in patients with idiopathic dilated cardiomyopathy.
Mogensen J; Murphy RT; Shaw T; Bahl A; Redwood C; Watkins H; Burke M; Elliott PM; McKenna WJ
J Am Coll Cardiol; 2004 Nov; 44(10):2033-40. PubMed ID: 15542288
[TBL] [Abstract][Full Text] [Related]
16. Dilated cardiomyopathy mutation (R174W) in troponin T attenuates the length-mediated increase in cross-bridge recruitment and myofilament Ca
Reda SM; Chandra M
Am J Physiol Heart Circ Physiol; 2019 Sep; 317(3):H648-H657. PubMed ID: 31373515
[TBL] [Abstract][Full Text] [Related]
17. [Correlation of cardiac troponin T gene mutations to hypertrophic cardiomyopathy in Chinese patients].
Li M; Cheng K; Wang QB; Zhu WQ; Chen RZ; Ge JB; Chen HZ
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Sep; 31(9):1589-91. PubMed ID: 21945774
[TBL] [Abstract][Full Text] [Related]
18. Alterations in thin filament regulation induced by a human cardiac troponin T mutant that causes dilated cardiomyopathy are distinct from those induced by troponin T mutants that cause hypertrophic cardiomyopathy.
Robinson P; Mirza M; Knott A; Abdulrazzak H; Willott R; Marston S; Watkins H; Redwood C
J Biol Chem; 2002 Oct; 277(43):40710-6. PubMed ID: 12186860
[TBL] [Abstract][Full Text] [Related]
19. Hypertrophic cardiomyopathy: low frequency of mutations in the beta-myosin heavy chain (MYH7) and cardiac troponin T (TNNT2) genes among Spanish patients.
García-Castro M; Reguero JR; Batalla A; Díaz-Molina B; González P; Alvarez V; Cortina A; Cubero GI; Coto E
Clin Chem; 2003 Aug; 49(8):1279-85. PubMed ID: 12881443
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of allele discrimination by introduction of nucleotide mismatches into siRNA in allele-specific gene silencing by RNAi.
Ohnishi Y; Tamura Y; Yoshida M; Tokunaga K; Hohjoh H
PLoS One; 2008 May; 3(5):e2248. PubMed ID: 18493311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
